Afghanyar, Yama; Traub, Frank; Jorg, Tobias
Idiopathic Craniocervical Hyperpneumatization with PneumorrhachisDEUTSCHES ARZTEBLATT INTERNATIONAL. Bd. 121. H. 20. 2024 S. 688-688
Lemmer, Dana; Ruck, Tobias; Schaenzer, Anne et al.
Idiopathic inflammatory myopathies: An interdisciplinary challengeZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 83. H. 6. 2024 S. 471-484
Lang, Berenice M.; Zielbauer, Sebastian; Stege, Henner et al.
If patients had a choice - Treatment satisfaction and patients' preference in therapy of actinic keratosesJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 22. H. 10. 2024 S. 1362-1368
Potapova, Ekaterina; Tripodi, Salvatore; Panetta, Valentina et al.
IgE to cross-reactive carbohydrate determinants (CCD) in childhood: Prevalence, risk factors, putative originsCLINICAL AND EXPERIMENTAL ALLERGY. Bd. 54. H. 3. 2024 S. 195-206
Heinl, Patricia Vanessa; Graulich, Edith; Weigmann, Benno et al.
IL-10-modulated dendritic cells from birch pollen- and hazelnut-allergic patients facilitate Treg-mediated allergen-specific and cross-reactive toleranceALLERGY. Bd. 79. H. 10. 2024 S. 2826-2839
Mekschrat, Liza; Schmalbach, Bjarne; Rohleder, Nicolas et al.
IL-6 after wake-up in human males: Exposure to red versus blue light and the interplay with cortisolBRAIN BEHAVIOR & IMMUNITY-HEALTH. Bd. 40. 2024
Ward, Chris; Curry, Nicola; El-Ekiaby, Magdy et al.
Illustrated State-of-the-Art Capsules of the ISTH 2024 CongressRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. Bd. 8. H. 4. 2024
Ward, Chris; Curry, Nicola; El-Ekiaby, Magdy et al.
Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress (vol 8, 102432, 2024)RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. Bd. 8. H. 4. 2024
Khristenko, Ekaterina; Gaida, Matthias M.; Tjaden, Christine et al.
Imaging differentiation of solid pseudopapillary neoplasms and neuroendocrine neoplasms of the pancreasEUROPEAN JOURNAL OF RADIOLOGY OPEN. Bd. 12. 2024
Finn, Richard S.; Breder, Valeriy; Vogel, Arndt et al.
IMBRAVE150: EXPLORATORY EFFICACY AND SAFETY RESULTS OF HEPATOCELLULAR CARCINOMA (HCC) PATIENTS (PTS) WITH MAIN TRUNK AND/OR CONTRALATERAL PORTAL VEIN INVASION (VP4) TREATED WITH ATEZOLIZUMAB (ATEZO) plus BEVACIZUMAB (BEV) VS SORAFENIB (SOR) IN A PH III STUDYGASTROENTEROLOGY. Bd. 166. H. 5. 2024 S. S1738-S1738